Breckenridge Pharmaceutical, Inc: Solifenacin Succinate Tablets Recalled Due to Potential Chemical Conversion

What You Should Do

1. Check your medication bottle for Solifenacin Succinate Tablets, 5mg. Affected products include 30-count bottles (NDC 51991-893-33) with lot numbers 81244 or 81217, and 90-count bottles (NDC 51991-893-90) with lot number 81245. All affected 5mg lots have an expiration date of 01/2021.
2. Check your medication bottle for Solifenacin Succinate Tablets, 10mg. Affected products include 30-count bottles (NDC 51991-894-33) with lot numbers 81253 or 81272, and 90-count bottles (NDC 51991-894-90) with lot number 81268. All affected 10mg lots have an expiration date of 01/2021.
3. Contact your healthcare provider or pharmacist immediately to discuss your treatment and obtain a replacement prescription if your medication is part of the recall.
4. Return any unused or affected medication to your pharmacy to request a refund and ensure the product is disposed of correctly.
5. Contact Breckenridge Pharmaceutical, Inc. at their Berlin, Connecticut headquarters for further instructions regarding this recall.
6. For additional questions or to report a complaint, contact the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Affected Products